https://www.globenewswire.com/news-release/2026/04/16/3275450/0/en/Fate-Therapeutics-Announces-Data-Presentation-of-FT839-Next-Generation-Off-The-Shelf-CAR-T-Cell-Product-Candidate-for-the-Broad-Treatment-of-Hematological-Malignancies-and-Autoimmu.html
Fate Therapeutics Announces Data Presentation of FT839
SAN DIEGO, April 16, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a...
data presentationfatetherapeuticsannouncesft839